The United States usually doesn’t fare very well in international health comparisons. The country’s healthcare ranks among, if not the, most expensive. The outcomes, as measured by metrics such as life expectancy at birth, are not top tier, especially when the U.S. is compared to well-off countries in Europe and Asia.
The United States usually doesn’t fare very well in international health comparisons. The country’s healthcare ranks among, if not the, most expensive. The outcomes, as measured by metrics such as life expectancy at birth, are not top tier, especially when the U.S. is compared to well-off countries in Europe and Asia.
The story with COVID-19 is similar, according to data reported recently by Kaiser Family Foundation. Among the dozen developed countries included in the foundation’s analysis, only Belgium, at 90.4 COVID-19-related deaths per 100,000 population, was worse than the U.S., at 66.5 COVID-19 deaths per 100,000. By contrast, Japan’s rate of 1.3 COVID-19 deaths per 100,000 is stunningly low, as is Australia’s (3.6 per 100,000) and Germany’s (11.7 per 100,000).
Kaiser’s ranking of the leading causes of death is also sobering. COVID-19 is on course to being the third leading cause of death in the U.S. in 2020, behind only the perennial leaders, heart disease and cancer. In Japan, COVID-19 is on track to being the 29th leading cause of death and in Germany, the 17th
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More